RTW Biotech Opportunities (LON:RTW – Get Free Report)’s share price traded down 3.5% on Wednesday . The company traded as low as GBX 1.10 ($0.01) and last traded at GBX 1.10 ($0.01). 265,996 shares traded hands during trading, an increase of 20% from the average session volume of 221,595 shares. The stock had previously closed at GBX 1.14 ($0.01).
RTW Biotech Opportunities Stock Down 3.5 %
The company has a market cap of £369.51 million, a PE ratio of 2.62 and a beta of 0.60. The company’s fifty day moving average is GBX 1.28 and its 200-day moving average is GBX 1.41.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Recommended Stories
- Five stocks we like better than RTW Biotech Opportunities
- How to Profit From Value Investing
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- Most Volatile Stocks, What Investors Need to Know
- Are Tariffs Threatening Disney’s Comeback Story?
- Growth Stocks: What They Are, Examples and How to Invest
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
